Jessica Caldwell, PhD, ABPP
Visiting Associate Professor of Neurology
Department of Neurology
Multi-Principal Investigator
Wisconsin Registry for Alzheimer’s Prevention (WRAP)
University of Wisconsin School of Medicine and Public Health

Dr. Caldwell is the multi-principal investigator of the Wisconsin Registry for Alzheimer’s Prevention (WRAP) study. Dr. Caldwell is a board-certified neuropsychologist and a visiting associate professor in the Department of Neurology at UW-Madison. She also earned her Ph.D. in clinical psychology with a minor in neuroscience at UW-Madison and completed predoctoral internship at Harvard Medical School, and a postdoctoral fellowship at Brown University. Dr. Caldwell’s research focuses on sex and gender influences on Alzheimer’s disease risk and resilience, including how hormones and gender roles impact risk for developing Alzheimer’s disease. Her research also examines dementia prevention and both pharmacological and non-pharmacological approaches to dementia prevention.

Dr. Cynthia Carlsson is Professor of Medicine in the Division of Geriatrics at the University of Wisconsin School of Medicine and Public Health and Director of the Wisconsin Alzheimer’s Institute in Madison, Wisconsin. Her research focuses on early detection and prevention of Alzheimer’s disease through modification of vascular risk factors. She has received grant support from the National Institutes of Health (NIH), the Department of Veterans Affairs, the University of Wisconsin, and other organizations and has published over 200 peer-reviewed research papers. Dr. Carlsson serves as Clinical Core Leader of the NIH-funded Wisconsin Alzheimer’s Disease Research Center and leads the University of Wisconsin Alzheimer’s disease clinical trials program as a member site in the NIH Alzheimer’s Clinical Trials Consortium (ACTC). She has been a part of state and national initiatives to improve dementia research, clinical care, and services for older adults, including serving as Chair for the US Health and Human Services Advisory Council on Alzheimer’s Research, Care, and Services. She continues to see patients with memory loss at the Madison Veterans Affairs Hospital where she has served as a staff geriatrician for over 20 years.

Laura Eisenmenger, MD
Associate Professor
Associate Chief of MRI
Medical Director of Imaging Services
Wisconsin Institutes for Medical Research
University of Wisconsin School of Medicine and Public Health

Laura Eisenmenger, MD, is an Associate Professor of Radiology (tenure track) in the Neuroradiology Section. Dr. Eisenmenger graduated summa cum laude from Illinois Wesleyan University, Bloomington, IL. She earned her MD at Ohio State University College of Medicine, Columbus, graduating magna cum laude. She completed an internship at Riverside Methodist Hospital, Columbus, and a Diagnostic Radiology residency at University of Utah, Salt Lake City. Dr. Eisenmenger was President of the Utah Medical Association Resident Executive Committee in 2016-2017. She has received multiple research grants including the Radiological Society of North America (RSNA) Resident Research Grant in 2017, the Roentgen Resident Research Award in 2017, and the RSNA Fellow Research Grant in 2018. Dr. Eisenmenger completed her Neuroradiology fellowship at the University of California-San Francisco in the Department of Radiology and Biomedical Imaging, where she was a Chief Fellow in 2017-2018. In the seven years since completing training, Dr. Eisenmenger has been a principal investigator on an R01 investigating sensitive and specific detection of vascular contributions to dementia, achieved through an advanced MRI flow study of subjects with CASDASIL and a “normal” aging cohort. In addition, she was principal investigator on a NIH KL2 award developing new MRI protocols for the measurement of cerebrovascular reactivity in Alzheimer’s disease (AD), a Wisconsin Alzheimer's Disease Research Center (WI-ADRC) developmental grant to evaluate arterial spin labeling in the study of altered blood brain barrier permeability, as well as successfully been co-investigator on eight R01s, one U01, one R03, one R21, and multiple society/intuitional grants. Her scientific interests are focused on clinical implementation of novel imaging approaches, with a particular interest in MR imaging and how it can be applied to Alzheimer's Disease and Related Dementias.

Donna M. Fick, PhD, RN, FGSA, AGSF, FAAN 
Elouise Ross Eberly Endowed Professor  
Ross and Carol Nese College of Nursing,
Penn State
Director, Tressa Nese and Helen Diskevich Center of Geriatric Nursing Excellence
Editor, Journal of Gerontological Nursing

Dr. Donna Marie Fick is the Elouise Ross Eberly Endowed Professor of the Ross & Carol Nese College of Nursing at The Pennsylvania State University, and Director of the Tressa Nese and Helen Diskevich Center of Geriatric Nursing Excellence. Dr. Fick is best known for her NIH funded work on mentation, delirium, delirium superimposed on dementia (DSD) and ultra-brief delirium detection at the bedside. Along with Dr. Marcantonio at Harvard/Beth Israel Deaconess and their team, she has transformed the way clinicians approach delirium and DSD.  Their tools, the UB-2 and UB-CAM, are used in health systems across the world. She is Past President of the  American Geriatrics Society (the third nurse in their 80-year history) and has been a member or co-chair of the interdisciplinary panel for the American Geriatrics Society Beers Criteria for inappropriate medication use in older adults since 2002. She teaches research and gerontology courses at Penn State and serves as a faculty and advisory member on Creating an Age Friendly Health System Initiative with the John A. Hartford Foundation and the Institute for Healthcare Improvement, and the Revisiting the Teaching Nursing Home Project.  Dr. Fick has completed as PI & MPI four NIH funded R01s on delirium in persons with dementia and is in year 3 of a 5-year implementation study. Her goal in her research, teaching and service is to improve the care of older adults, persons with disabilities, and their care partners. She lives in rural PA near her three adult children and enjoys gardening and trail running in the mountains.

Joseph E. Gaugler, PhD
Director, State Alzheimer's Research Support Center
Division of Health Policy and Management
School of Public Health
University of Minnesota

Joe Gaugler is the Robert L. Kane Endowed Chair in Long-Term Care & Aging in the School of Public Health and a Distinguished McKnight University Professor at the University of Minnesota. He is the Director of the Center for Healthy Aging and Innovation, Director of the CDC-funded BOLD Public Health Center of Excellence on Dementia Caregiving, Director of the National Institute on Aging-funded EMBRACE AD/ADRD Roybal and State Alzheimer's Research Support Centers, and Editor-in-Chief of The Gerontologist. His research focuses on dementia care innovation.

Jennifer J. Manly, PhD
Professor
Taub Institute for Research on Alzheimer’s Disease & the Aging Brain
Department of Neurology
Vagelos College of Physicians & Surgeons
Columbia University Irving Medical Center

Jennifer J. Manly, Ph.D. is a Professor of Neuropsychology in the Department of Neurology at Columbia University Irving Medical Center. Her research focuses on mechanisms of inequalities in cognitive aging and Alzheimer’s Disease. Her research team has partnered with the Black and Latino communities in New York City and around the United States to design and carry out investigations of structural and social forces across the lifecourse, such as educational opportunities, discrimination, and socioeconomic inequality, and how these factors relate to cognition and brain health later in life. She is the recipient of several mentor awards, was elected to the National Academy of Medicine, and is a current member of the NIH Council of Councils.

Henrik Zetterberg, MD, PhD
Professor
Biomarker Core Co-Leader
Alzheimer's Disease Research Center
University of Wisconsin School of Medicine and Public Health

Dr. Zetterberg is a professor of neurochemistry and head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg, a consultant in clinical chemistry at the Sahlgrenska University Hospital, and a visiting professor at UW−Madison and at University College London. He has received the Erik K. Fernström Prize for Junior Scientists, the Inga Sandeborg Prize for Research on Alzheimer’s disease and the 2024 Goodes Prize. Dr. Zetterberg currently focuses on the development of biomarkers for Alzheimer’s and related dementias and the development of diagnostic tests and new monitoring tools for the diseases.